Close Menu

NEW YORK (GenomeWeb News) – French diagnostics firm Theradiag and its collaborators in South Korea have been awarded a three-year grant from the European Commission to develop tests for rectal cancer based on microRNA and messenger RNA signatures, the company announced yesterday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.